|
1
|
Karmazyn B, Weatherly DL, Lehnert SJ, Cain MP, Fan R, Jennings SG, Ouyang F and Kaefer M: Characteristics of testicular tumors in prepubertal children (age 5-12 years). J Pediatr Urol. 14:259.e1–259.e6. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Juliachs M, Muñoz C, Moutinho CA, Vidal A, Condom E, Esteller M, Graupera M, Casanovas O, Germà JR, Villanueva A and Viñals F: The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin Cancer Res. 20:658–667. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wang X, Xu S, Tang D, Li M, Wu D and Huang Y: Prepubertal testicular and paratesticular tumors in China: A single-center experience over a 10-year period. J Pediatr Surg. 47:1576–1580. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Berney DM, Lu YJ, Shamash J and Idrees M: Postchemotherapy changes in testicular germ cell tumours: Biology and morphology. Histopathology. 70:26–39. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Rathore R, McCallum JE, Varghese E, Florea AM and Büsselberg D: Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Apoptosis. 22:898–919. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kocab AJ and Duckett CS: Inhibitor of apoptosis proteins as intracellular signaling intermediates. FEBS J. 283:221–231. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mohamed MS, Bishr MK, Almutairi FM and Ali AG: Inhibitors of apoptosis: Clinical implications in cancer. Apoptosis. 22:1487–1509. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Fulda S: Molecular pathways: Targeting inhibitor of apoptosis proteins in cancer-from molecular mechanism to therapeutic application. Clin Cancer Res. 20:289–295. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Rada M, Nallanthighal S, Cha J, Ryan K, Sage J, Eldred C, Ullo M, Orsulic S and Cheon DJ: Inhibitor of apoptosis proteins (IAPs) mediate collagen type XI alpha 1-driven cisplatin resistance in ovarian cancer. Oncogene. 37:4809–4820. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Checinska A, Hoogeland B, Rodriguez JA, Giaccone G and Kruyt FA: Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: A small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation. Exp Cell Res. 313:1215–1224. 2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dawood S, Austin L and Cristofanilli M: Cancer stem cells: Implications for cancer therapy. Oncology (Williston Park). 28:1101–1107, 1110. 2014.PubMed/NCBI
|
|
12
|
Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med. 355:1253–1261. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Trosko JE: Evolution of energy metabolism, stem cells and cancer stem cells: How the Warburg and Barker hypothesis might be linked. BMC Proc. 7 (Suppl 2)(K8)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Pacini N and Borziani F: Cancer stem cell theory and the warburg effect, two sides of the same coin? Int J Mol Sci. 15:8893–8930. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Vaupel P, Schmidberger H and Mayer A: The Warburg effect: Essential part of metabolic reprogramming and central contributor to cancer progression. Int J Radiat Biol. 95:912–919. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schwartz L, Supuran CT and Alfarouk KO: The warburg effect and the hallmarks of cancer. Anticancer Agents Med Chem. 17:164–170. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ji J, Yu Y, Li ZL, Chen MY, Deng R, Huang X, Wang GF, Zhang MX, Yang Q, Ravichandran S, et al: XIAP limits autophagic degradation of Sox2 and is a therapeutic target in nasopharyngeal carcinoma stem cells. Theranostics. 8:1494–1510. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ausserlechner MJ and Hagenbuchner J: Mitochondrial survivin-an Achilles' heel in cancer chemoresistance. Mol Cell Oncol. 3(e1076589)2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K and Mueller-Lantzsch N: Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene. 24:3223–3228. 2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS and Dixit VM: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol. 10:1359–1366. 2000.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ashhab Y, Alian A, Polliack A, Panet A and Ben Yehuda D: Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern. FEBS Lett. 495:56–60. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS and Reed JC: IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:2215–2223. 1998.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Roy N, Deveraux QL, Takahashi R, Salvesen GS and Reed JC: The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914–6925. 1997.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Green DR and Evan GI: A matter of life and death. Cancer Cell. 1:19–30. 2002.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Epstein T, Gatenby RA and Brown JS: The Warburg effect as an adaptation of cancer cells to rapid fluctuations in energy demand. PLoS One. 12(e0185085)2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vander Heiden MG, Locasale JW, Swanson KD, Sharfi H, Heffron GJ, Amador-Noguez D, Christofk HR, Wagner G, Rabinowitz JD, Asara JM and Cantley LC: Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science. 329:1492–1499. 2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang YD, Li SJ and Liao JX: Inhibition of glucose transporter 1 (GLUT1) chemosensitized head and neck cancer cells to cisplatin. Technol Cancer Res Treat. 12:525–535. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer. 8:755–768. 2008.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lu Y, Zhu H, Shan H, Lu J, Chang X, Li X, Lu J, Fan X, Zhu S, Wang Y, et al: Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells. Cancer Lett. 340:113–123. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Santini R, Pietrobono S, Pandolfi S, Montagnani V, D'Amico M, Penachioni JY, Vinci MC, Borgognoni L and Stecca B: SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells. Oncogene. 33:4697–4708. 2014.PubMed/NCBI View Article : Google Scholar
|
